PL369498A1 - Sposób odzyskiwania i oczyszczania poxywirusów z zainfekowanych komórek - Google Patents

Sposób odzyskiwania i oczyszczania poxywirusów z zainfekowanych komórek

Info

Publication number: PL369498A1
Authority: PL; Poland
Prior art keywords: infected cells; poxviruses; recovery; virus; purification
Prior art date: 2001-12-20

Application number

PL02369498A

Other languages

English (en)

Other versions

PL205929B1 (pl

Inventor

Karl Heller

Jutta Kramer

Original Assignee

Bavarian Nordic A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-20

Filing date

2002-12-13

Publication date

2005-04-18

2002-12-13 Application filed by Bavarian Nordic A/S filed Critical Bavarian Nordic A/S

2005-04-18 Publication of PL369498A1 publication Critical patent/PL369498A1/pl

2010-06-30 Publication of PL205929B1 publication Critical patent/PL205929B1/pl

Links

238000000034 method Methods 0.000 title abstract 3
238000000746 purification Methods 0.000 title abstract 2
238000011084 recovery Methods 0.000 title abstract 2
241000700605 Viruses Species 0.000 abstract 4
241001183012 Modified Vaccinia Ankara virus Species 0.000 abstract 2
238000000265 homogenisation Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24151—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Mycology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Compounds Of Unknown Constitution (AREA)
Meat, Egg Or Seafood Products (AREA)
Investigating Or Analysing Biological Materials (AREA)

PL369498A 2001-12-20 2002-12-13 Sposób odzyskiwania i oczyszczania poxywirusów z zainfekowanych komórek PL205929B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200101928		2001-12-20

Publications (2)

Publication Number	Publication Date
PL369498A1 true PL369498A1 (pl)	2005-04-18
PL205929B1 PL205929B1 (pl)	2010-06-30

Family

ID=8160920

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL369498A PL205929B1 (pl)	2001-12-20	2002-12-13	Sposób odzyskiwania i oczyszczania poxywirusów z zainfekowanych komórek

Country Status (22)

Country	Link
US (1)	US7056723B2 (pl)
EP (1)	EP1407006B9 (pl)
JP (2)	JP5322252B2 (pl)
KR (1)	KR100947976B1 (pl)
CN (1)	CN1289663C (pl)
AT (1)	ATE302268T1 (pl)
AU (1)	AU2002352247B2 (pl)
BR (1)	BRPI0215003B1 (pl)
CA (1)	CA2467099C (pl)
DE (1)	DE60205631T2 (pl)
DK (1)	DK1407006T3 (pl)
EA (1)	EA006485B1 (pl)
ES (1)	ES2247404T3 (pl)
HU (1)	HU227507B1 (pl)
IL (2)	IL161526A0 (pl)
MX (1)	MXPA04006001A (pl)
NO (1)	NO335975B1 (pl)
NZ (1)	NZ533586A (pl)
PL (1)	PL205929B1 (pl)
SI (1)	SI1407006T1 (pl)
UA (1)	UA77735C2 (pl)
WO (1)	WO2003054175A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7445924B2 (en) *	2000-11-23	2008-11-04	Bavarian Nordic A/S	Modified Vaccinia Ankara virus variant and cultivation method
HU230198B1 (hu) *	2000-11-23	2015-10-28	Bavarian Nordic A/S	Módosított Vacciniavírus Ankara-variáns
AU2003264144C1 (en)	2002-09-05	2009-12-17	Bavarian Nordic A/S	Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
US7951576B2 (en) *	2004-11-05	2011-05-31	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods for preparing cells and viruses
US7625570B1 (en) *	2005-03-10	2009-12-01	The Regents Of The University Of California	Methods for purifying adeno-associated virus
US8003363B2 (en)	2007-05-14	2011-08-23	Bavarian Nordic A/S	Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
AU2008250596C1 (en) *	2007-05-14	2010-11-25	Bavarian Nordic A/S	Purification of Vaccinia virus- and recombinant Vaccinia virus-based vaccines
AU2009214768B2 (en) *	2008-02-12	2015-01-22	Sanofi Pasteur Limited	Methods using ion exchange and gel filtration chromatography for poxvirus purification
SG176554A1 (en) *	2009-05-12	2012-01-30	Transgene Sa	Method for orthopoxvirus production and purification
FR2953686B1 (fr)	2009-12-14	2012-11-02	Agronomique Inst Nat Rech	Procede pour reduire la teneur bacterienne d'un milieu alimentaire et/ou biologique d'interet, contenant des gouttelettes lipidiques
CA2802430C (en)	2010-07-20	2021-07-20	Bavarian Nordic A/S	Method for harvesting poxvirus
CN102353792A (zh) *	2011-07-07	2012-02-15	贵州大学	一种基于gpv p32蛋白的间接elisa试剂盒及制备方法
FR3042121A1 (fr)	2015-10-08	2017-04-14	Jean-Marc Limacher	Composition anti-tumorale
EP3624851A1 (en)	2017-05-15	2020-03-25	Janssen Vaccines & Prevention B.V.	Stable virus-containing composition
CA3062549A1 (en)	2017-05-15	2018-11-22	Janssen Vaccines & Prevention B.V.	Stable virus-containing composition
EP3847246A1 (en)	2018-09-06	2021-07-14	Bavarian Nordic A/S	Storage improved poxvirus compositions
JP7712284B2 (ja)	2020-03-12	2025-07-23	バヴァリアン・ノルディック・アクティーゼルスカブ	ポックスウイルスの安定性を改善する組成物
JP2025524459A (ja)	2022-06-29	2025-07-30	バヴァリアン・ノルディック・アクティーゼルスカブ	エプスタイン・バー・ウイルスワクチン
IL317745A (en)	2022-06-29	2025-02-01	Bavarian Nordic As	Modified recombinant SARNA (VRP) and Vaccinia Ankara virus (MVA) prime regimen
CN115197966A (zh) *	2022-08-15	2022-10-18	深圳源兴基因技术有限公司	一种利用生物反应器大规模生产重组痘苗病毒载体的方法
FR3160186A1 (fr)	2024-03-13	2025-09-19	Odimma Therapeutics	Vecteur non-viral pour transcription augmentee
FR3171450A1 (fr)	2025-01-17	2026-07-24	Odimma Therapeutics	Virus enveloppé pour la transfection d’acides nucléiques exogènes.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB877898A (en)	1956-12-06	1961-09-20	Apv Co Ltd	A new or improved method of liberating enzymes
JPS5328989B2 (pl) *	1974-05-27	1978-08-17
CH621573A5 (en)	1976-08-05	1981-02-13	Vnii Biosinteza Belkovykh Vesc	Process for the continuous disintegration of microorganism cells and system for carrying out this process
JPS54154594A (en) *	1978-05-25	1979-12-05	Sumitomo Chem Co Ltd	Extraction of glucose isomerase
WO1991001367A1 (en) *	1989-07-20	1991-02-07	Bioeng, Inc.	Supercritical fluid disruption of and extraction from microbial cells
UA68327C2 (en) *	1995-07-04	2004-08-16	Gsf Forschungszentrum Fur Unwe	A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
TW426733B (en)	1995-10-06	2001-03-21	Merck & Co Inc	Method of disrupting cultured cells using an impinging jet device
ID19548A (id) *	1996-09-24	1998-07-23	Bavarian Nordic Res Inst As	Virus mva rekombinan yang mengekspresikan antigen-antigen virus demam dan penggunaan daripadanya dalam vaksin-vaksin
US5721120A (en) *	1996-10-02	1998-02-24	Merck & Co., Inc.	Method of disrupting cultured cells using an impinging jet device
NZ299720A (en) *	1996-11-08	1999-07-29	Howick Engineering Ltd	Epicyclic input/output annuli of same pcd, with planetary input/output gear sets, and with only one set having aligned teeth
EP0968284B1 (en) *	1996-11-20	2006-12-13	Introgen Therapeutics, Inc.	An improved method for the production and purification of adenoviral vectors
US6000551A (en) *	1996-12-20	1999-12-14	Eastman Chemical Company	Method for rupturing microalgae cells
FR2787465A1 (fr) *	1998-12-21	2000-06-23	Transgene Sa	Procede d'inactivation des virus enveloppes dans une preparation virale de virus non enveloppes
CA2364934C (fr) *	1999-02-22	2011-10-18	Transgene S.A.	Procede d'obtention d'une preparation virale purifiee
DE19918619A1 (de)	1999-04-23	2000-10-26	Rhein Biotech Proz & Prod Gmbh	Verfahren zum Gewinnen von rekombinantem HBsAg
US6951752B2 (en) *	2001-12-10	2005-10-04	Bexter Healthcare S.A.	Method for large scale production of virus antigen

2002
- 2002-12-13 US US10/495,151 patent/US7056723B2/en not_active Expired - Lifetime
- 2002-12-13 HU HU0402337A patent/HU227507B1/hu not_active IP Right Cessation
- 2002-12-13 DE DE60205631T patent/DE60205631T2/de not_active Expired - Lifetime
- 2002-12-13 EA EA200400833A patent/EA006485B1/ru not_active IP Right Cessation
- 2002-12-13 NZ NZ533586A patent/NZ533586A/en not_active IP Right Cessation
- 2002-12-13 JP JP2003554879A patent/JP5322252B2/ja not_active Expired - Fee Related
- 2002-12-13 CA CA2467099A patent/CA2467099C/en not_active Expired - Fee Related
- 2002-12-13 AU AU2002352247A patent/AU2002352247B2/en not_active Ceased
- 2002-12-13 CN CNB028255267A patent/CN1289663C/zh not_active Expired - Fee Related
- 2002-12-13 ES ES02787945T patent/ES2247404T3/es not_active Expired - Lifetime
- 2002-12-13 AT AT02787945T patent/ATE302268T1/de active
- 2002-12-13 DK DK02787945T patent/DK1407006T3/da active
- 2002-12-13 UA UA20040705906A patent/UA77735C2/uk unknown
- 2002-12-13 IL IL16152602A patent/IL161526A0/xx unknown
- 2002-12-13 EP EP02787945A patent/EP1407006B9/en not_active Expired - Lifetime
- 2002-12-13 MX MXPA04006001A patent/MXPA04006001A/es active IP Right Grant
- 2002-12-13 BR BRPI0215003A patent/BRPI0215003B1/pt not_active IP Right Cessation
- 2002-12-13 KR KR1020047009777A patent/KR100947976B1/ko not_active Expired - Fee Related
- 2002-12-13 WO PCT/EP2002/014179 patent/WO2003054175A1/en not_active Ceased
- 2002-12-13 SI SI200230220T patent/SI1407006T1/sl unknown
- 2002-12-13 PL PL369498A patent/PL205929B1/pl unknown
2004
- 2004-04-20 IL IL161526A patent/IL161526A/en not_active IP Right Cessation
- 2004-07-19 NO NO20043181A patent/NO335975B1/no not_active IP Right Cessation
2009
- 2009-11-19 JP JP2009263687A patent/JP2010046093A/ja active Pending

Also Published As

Publication number	Publication date
KR100947976B1 (ko)	2010-03-15
US20040265986A1 (en)	2004-12-30
HUP0402337A2 (hu)	2005-01-28
CN1289663C (zh)	2006-12-13
DK1407006T3 (da)	2005-12-12
IL161526A0 (en)	2004-09-27
UA77735C2 (en)	2007-01-15
HK1071765A1 (en)	2005-07-29
AU2002352247B2 (en)	2008-08-07
JP5322252B2 (ja)	2013-10-23
KR20040070263A (ko)	2004-08-06
EP1407006B9 (en)	2006-10-18
EP1407006A1 (en)	2004-04-14
CA2467099A1 (en)	2003-07-03
HU227507B1 (hu)	2011-07-28
HUP0402337A3 (en)	2010-01-28
CN1606616A (zh)	2005-04-13
DE60205631T2 (de)	2006-06-08
US7056723B2 (en)	2006-06-06
WO2003054175A1 (en)	2003-07-03
NO20043181L (no)	2004-07-19
NZ533586A (en)	2005-02-25
EP1407006B1 (en)	2005-08-17
EA200400833A1 (ru)	2004-12-30
JP2005512565A (ja)	2005-05-12
CA2467099C (en)	2013-01-29
SI1407006T1 (sl)	2006-04-30
EA006485B1 (ru)	2005-12-29
BR0215003A (pt)	2004-11-09
NO335975B1 (no)	2015-04-07
MXPA04006001A (es)	2005-08-19
IL161526A (en)	2009-11-18
JP2010046093A (ja)	2010-03-04
DE60205631D1 (de)	2005-09-22
AU2002352247A1 (en)	2003-07-09
BRPI0215003B1 (pt)	2017-03-14
ES2247404T3 (es)	2006-03-01
PL205929B1 (pl)	2010-06-30
ATE302268T1 (de)	2005-09-15

Publication	Publication Date	Title
IL161526A0 (en)	2004-09-27	Method for the recovery and purification of poxviruses from infected cells
WO2001064835A8 (en)	2002-02-14	Novel nucleic acids and polypeptides
NZ600629A (en)	2014-12-24	Vaccinia virus mutants containing the major genomic deletions of mva
BR0317091A (pt)	2005-10-25	Processo para preparação de 1-olefinas através da dissociação catalìtica de 1-alcoxialcanos
WO2004029781A3 (en)	2004-06-17	System for analyzing a capital structure
IL150168A0 (en)	2002-12-01	Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon
WO2003065037A3 (en)	2003-12-18	Method and apparatus for measuring membrane permeability
NZ597998A (en)	2013-08-30	Methods for treating cancer with mva
ATE399210T1 (de)	2008-07-15	Knockout-mutante von vaccinia-virus und verwendung davon
ATE521627T1 (de)	2011-09-15	Identifikation kreuzreaktiver epitope des flavivirus-hüllglykoproteins
IL199126A (en)	2010-12-30	Promoters for expression in modified vaccinia virus ankara (mva) and vectors comprising said promoters.
NO20045440L (no)	2005-02-15	Vannloselig polymerdispersjon og fremgangsmate for a fremstille en vannloselig polymerdispersjon
WO2005027836A3 (en)	2006-01-12	Immunogen
WO2022039822A8 (en)	2023-06-15	Methods and compositions for treating coronavirus infections
DE60206091T2 (de)	2006-06-14	Methoden zum Betreiben von Gasturbinen
WO2002072803A3 (en)	2003-08-14	Subgenomic replicons of the flavivirus dengue
DE60302848D1 (de)	2006-01-26	Expression von genen im modifizierten vaccinia virus ankara durch verwendung eines cowpox ati promoter
FR2849375B1 (fr)	2006-10-20	Compositions cosmetiques, par exemple pour traiter le vieillissement cutane photo-induit
DK1322701T3 (da)	2005-03-21	Forgitringshæmmende sammensætning
MXPA03008113A (es)	2003-12-12	Prodecimiento para preparar una placa de valvula resistente al agrietamiento.
MXPA03010498A (es)	2004-05-27	Proceso para la preparacion de imipenem.
WO2003046137A3 (en)	2004-02-05	Hiv envelope v3-ccr5 binding site immunogen
AU2003277909A1 (en)	2004-05-13	Recombinant mva strains as potential vaccines against p. falciparum malaria
WO2006052826A3 (en)	2006-10-12	Methods for preparing cells and viruses
WO2002087499A3 (en)	2003-12-04	Cells for detection of enteroviruses